Kellie M. Tainton

2.2k citations

19 papers · 1.5k indexed · h-index 14

Co-authors: Ricky W. Johnstone Mark J. Smyth Astrid A. Ruefli Reinhard Kofler David Bernhard Michael J. Ausserlechner Vivien R. Sutton Alyssa E. Barry
Topics: Drug Transport and Resistance Mechanisms (6 papers)Immune Cell Function and Interaction (5 papers)Genomics and Chromatin Dynamics (3 papers)
Cited by: Oncology Molecular Biology Hematology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Genetics
Partner nations: Australia United States Austria

In The Last Decade

Kellie M. Tainton

19 papers receiving 1.5k citations

Peers

Countries citing papers authored by Kellie M. Tainton

Since Specialization

Citations

This map shows the geographic impact of Kellie M. Tainton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kellie M. Tainton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kellie M. Tainton more than expected).

Fields of papers citing papers by Kellie M. Tainton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kellie M. Tainton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kellie M. Tainton. The network helps show where Kellie M. Tainton may publish in the future.

Co-authorship network of co-authors of Kellie M. Tainton

This figure shows the co-authorship network connecting the top 25 collaborators of Kellie M. Tainton. A scholar is included among the top collaborators of Kellie M. Tainton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kellie M. Tainton. Kellie M. Tainton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy 2013 ·Clinical & Experimental Immunology ·(unknown),Paul J. Neeson,Edwin Leeansyah,Kellie M. Tainton,Hang Quach,H. Miles Prince,Simon J. Harrison,Dale I. Godfrey,David Ritchie,Stuart P. Berzins	39
2	Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients 2010 ·Leukemia ·(unknown),Paul J. Neeson,Edwin Leeansyah,Kellie M. Tainton,Hang Quach,H. Miles Prince,Dale I. Godfrey,David Ritchie,Stuart P. Berzins	31
3	Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype 2010 ·Gene Therapy ·Paul J. Neeson,(unknown),Kellie M. Tainton,(unknown),H. Miles Prince,Simon J. Harrison,Stefan Peinert,Mark J. Smyth,Joseph A. Trapani,Michael H. Kershaw,Phillip K. Darcy,David Ritchie	36
4	Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen 2010 ·Gene Therapy ·Stefan Peinert,H. Miles Prince,(unknown),Michael H. Kershaw,Mark J. Smyth,Joseph A. Trapani,Peter Gambell,Simon J. Harrison,Andrew M. Scott,Fiona E. Smyth,Phillip K. Darcy,Kellie M. Tainton,Paul J. Neeson,David Ritchie,Dirk Hönemann	98
5	Regulatory T Cells (Treg) Are Depressed in Patients with Relapsed/Refractory Multiple Myeloma (MM) and Increases towards Normal Range in Responding Patients Treated with Lenalidomide (LEN). 2008 ·Blood ·Hang Quach,David Ritchie,Paul J. Neeson,Simon J. Harrison,Tsin Yee Tai,Kellie M. Tainton,Kevin Lynch,Miles Prince	8
6	Cloning and characterisation of Ifi206: A new murine HIN‐200 family member 2007 ·Journal of Cellular Biochemistry ·Louise Ludlow,Linda Hii,(unknown),Andrea Newbold,Kellie M. Tainton,Joseph A. Trapani,Christopher J. Clarke,Ricky W. Johnstone	8
7	G₂/M checkpoint gene expression in developing germ cells 2007 ·Molecular Reproduction and Development ·Suzanne Hasthorpe,Kellie M. Tainton,Melissa J. Peart,Kelly N. Roeszler,Katrina M. Bell,Patricia E. Lusby,John M. Hutson,Martin J. Tymms	6
8	Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux 2004 ·Cell Death and Differentiation ·Kellie M. Tainton,Mark J. Smyth,Jacob T. Jackson,Jane E. Tanner,Loretta Cerruti,Stephen M. Jane,Phillip K. Darcy,Ricky W. Johnstone	89
9	Novel mechanisms of apoptosis induced by histone deacetylase inhibitors. 2003 ·PubMed ·Melissa J. Peart,Kellie M. Tainton,Astrid A. Ruefli,Anthony E. Dear,Karin Sedelies,Lorraine A. O’Reilly,Nigel J. Waterhouse,Joseph A. Trapani,Ricky W. Johnstone	204
10	Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P‐glycoprotein‐expressing cells 2002 ·International Journal of Cancer ·Astrid A. Ruefli,David Bernhard,Kellie M. Tainton,Reinhard Kofler,Mark J. Smyth,Ricky W. Johnstone	68
11	P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation 2002 ·Cell Death and Differentiation ·Astrid A. Ruefli,Kellie M. Tainton,Phillip K. Darcy,Mark J. Smyth,Ricky W. Johnstone	64
12	P-glycoprotein Does Not Protect Cells against Cytolysis Induced by Pore-forming Proteins 2001 ·Journal of Biological Chemistry ·Ricky W. Johnstone,Kellie M. Tainton,Astrid A. Ruefli,Christopher J. Froelich,Loretta Cerruti,Stephen M. Jane,Mark J. Smyth	24
13	The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species 2001 ·Proceedings of the National Academy of Sciences ·Astrid A. Ruefli,Michael J. Ausserlechner,David Bernhard,Vivien R. Sutton,Kellie M. Tainton,Reinhard Kofler,Mark J. Smyth,Ricky W. Johnstone	410
14	The 10q25 Neocentromere and its Inactive Progenitor Have Identical Primary Nucleotide Sequence: Further Evidence for Epigenetic Modification 2000 ·Genome Research ·Alyssa E. Barry,(unknown),Emily V. Howman,Michael Cancilla,Kellie M. Tainton,Danielle V. Irvine,Richard Saffery,K. H. Andy Choo	35
15	Equivalent Death of P-Glycoprotein Expressing and Nonexpressing Cells Induced by the Protein Kinase C Inhibitor Staurosporine 2000 ·Biochemical and Biophysical Research Communications ·Kellie M. Tainton,Astrid A. Ruefli,Mark J. Smyth,Ricky W. Johnstone	13
16	A Role for P-Glycoprotein in Regulating Cell Death 2000 ·Leukemia & lymphoma ·Ricky W. Johnstone,(unknown),Kellie M. Tainton,Mark J. Smyth	96
17	Direct Cloning of Human 10q25 Neocentromere DNA Using Transformation-Associated Recombination (TAR) in Yeast 1998 ·Genomics ·Michael Cancilla,Kellie M. Tainton,Alyssa E. Barry,Vladimir Larionov,Natalya Kouprina,Michael A. Resnick,Desirée du Sart,K. H. Andy Choo	32
18	Rapid cloning of mouse DNA as yeast artificial chromosomes by transformation-associated recombination (TAR) 1998 ·Mammalian Genome ·(unknown),Joan P. Graves,Lydia E. Matesic,Roger H. Reeves,Kellie M. Tainton,K.H. Andy Choo,Michael A. Resnick,Vladimir Larionov,Natalya Kouprina	11
19	A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA 1997 ·Nature Genetics ·Desirée du Sart,Michael Cancilla,Elizabeth D. Earle,(unknown),Richard Saffery,Kellie M. Tainton,Paul Kalitsis,John C. Martyn,Alyssa E. Barry,K. H. Andy Choo	276

About Kellie M. Tainton

Kellie M. Tainton is a scholar working on Oncology, Immunology and Hematology, having authored 19 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Immune Cell Function and Interaction (5 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Oncology (533 citations), Molecular Biology (1.2k citations) and Hematology (166 citations). Kellie M. Tainton has collaborated with scholars based in Australia, United States and Austria. Frequent co-authors include Ricky W. Johnstone, Mark J. Smyth, Astrid A. Ruefli, Reinhard Kofler, David Bernhard, Michael J. Ausserlechner, Vivien R. Sutton, Alyssa E. Barry, Michael Cancilla and K. H. Andy Choo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact